We have proved through in vivo and in vitro experiments that normally processed BMSCs‐derived exosomes can increase the expression of H19 and play a role in the treatment of osteogenic differentiation and poor fracture healing caused by obesity. The gene discussed is H19; the disease is obesity due to melanocortin 4 receptor deficiency.